Tau Capital : TAU – results for 2013

Tau Capital has published its results for the year to the end of December 2013. These are somewhat academic now but, for what it’s worth, its NAV declined from $0.53 to $0.30. Since the year end its investment in Stopharm has been written down further.

James Carthew
Written By James Carthew

Head of Investment Company Research

Leave a Reply

Your email address will not be published. Required fields are marked *